Tower Research Capital (TRC)’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,380
| Closed | -$6K | – | 4721 |
|
|
2019
Q1 | $6K | Sell |
2,380
-7,480
| -76% | -$16.1K | ﹤0.01% | 3025 |
|
|
2018
Q4 | $16K | Buy |
9,860
+9,479
| +2,488% | +$17.7K | ﹤0.01% | 2147 |
|
|
2018
Q3 | $1K | Sell |
381
-4,985
| -93% | -$10.6K | ﹤0.01% | 3685 |
|
|
2018
Q2 | $10K | Buy |
+5,366
| New | +$8K | ﹤0.01% | 2815 |
|
|
2016
Q3 | – | Sell |
-339
| Closed | -$1K | – | 4944 |
|
|
2016
Q2 | $1K | Buy |
339
+82
| +32% | +$154 | ﹤0.01% | 4296 |
|
|
2016
Q1 | $0 | Buy |
257
+84
| +49% | +$137 | ﹤0.01% | 5363 |
|
|
2015
Q4 | $0 | Buy |
173
+71
| +70% | +$100 | ﹤0.01% | 5390 |
|
|
2015
Q3 | $0 | Sell |
102
-716
| -88% | -$847 | ﹤0.01% | 5173 |
|
|
2015
Q2 | $1K | Buy |
818
+620
| +313% | +$805 | ﹤0.01% | 4158 |
|
|
2015
Q1 | $0 | Sell |
198
-1,914
| -91% | -$2.76K | ﹤0.01% | 5201 |
|
|
2014
Q4 | $3K | Buy |
+2,112
| New | +$3.73K | ﹤0.01% | 3210 |
|
|
2014
Q3 | – | Sell |
-100
| Closed | – | – | 5134 |
|
|
2014
Q2 | $0 | Sell |
100
-200
| -67% | -$424 | ﹤0.01% | 4923 |
|
|
2014
Q1 | $1K | Sell |
300
-4,937
| -94% | -$10.5K | ﹤0.01% | 4274 |
|
|
2013
Q4 | $9K | Buy |
+5,237
| New | +$8.17K | ﹤0.01% | 3125 |
|
|
2013
Q3 | – | Sell |
-2,512
| Closed | -$4K | – | 5009 |
|
|
2013
Q2 | $4K | Buy |
+2,512
| New | +$4.65K | ﹤0.01% | 3156 |
|
Tower Research Capital (TRC)'s CASM Position: Q2 2019 in Review
Tower Research Capital (TRC) sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 2,380 shares — an estimated $6K sold.
Tower Research Capital (TRC) first reported a position in CASM in Q2 2013 and held it in 15 quarters. The position peaked at $16K in Q4 2018. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Tower Research Capital (TRC) reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,380 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $6K.
- Tower Research Capital (TRC) first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 15 quarters.
- Tower Research Capital (TRC)'s CAS Medical Systems, Inc. position peaked at $16K in Q4 2018.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.